Journal of Gastrointestinal Surgery

, Volume 20, Issue 4, pp 827–839 | Cite as

Primary Gastrointestinal Non-Hodgkin’s Lymphoma of the Small and Large Intestines: a Systematic Review

  • Amy L. LightnerEmail author
  • Evan Shannon
  • Melinda Maggard Gibbons
  • Marcia M. Russell
Original Article



Primary gastrointestinal non-Hodgkin’s lymphoma (PGINHL) of small and large intestines is a group of heterogeneous, rare malignancies. Optimal treatment practices remain undefined.


A systematic review (2003–2015) was performed to assess tumor characteristics, treatment practices, and treatment outcomes of PGINHL of small and large intestines.


Twenty-eight studies (1658 patients) were included; five focused on follicular lymphoma subtype. Of the non-follicular patients, 59.3 % presented with abdominal pain, 37.2 % were located in ileocecum, and 53.6 % were diffuse large B cell lymphoma subtype. The majority of patients (60.7 %) were treated with a combination of surgery and chemotherapy. Forty-three percent of studies concluded an overall survival benefit with surgery; none reported increased postoperative morbidity or mortality. Survival outcomes were not typically stratified by emergent versus elective surgery. Multivariate analysis within individual studies associated B cell lymphoma and ileocecum location with higher survival, while advanced stage and B symptoms were associated with poorer survival. Patients with asymptomatic follicular lymphoma had no progression with a watchful waiting approach.


The majority of patients with non-follicular small and large intestinal PGINHLs are treated with both chemotherapy and surgery. Although surgery appears to be an important part of the treatment algorithm, definitive statements regarding its survival benefit remain limited due to lack of patient stratification based on timing and indication for surgery.


Lymphoma Small intestine Large intestine Surgery Outcomes 


  1. 1.
    Halme L, Mecklin JP, Juhola M, Krees R, Palmu A. Primary gastrointestinal non-Hodgkin’s lymphoma. A population based study in central Finland in 1975–1993. Acta oncologica. 1997;36(1):69–74.CrossRefPubMedGoogle Scholar
  2. 2.
    Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. The hematology journal: the official journal of the European Haematology Association/EHA. 2002;3(2):95–104.CrossRefGoogle Scholar
  3. 3.
    Cheung MC, Housri N, Ogilvie MP, Sola JE, Koniaris LG. Surgery does not adversely affect survival in primary gastrointestinal lymphoma. Journal of surgical oncology. Jul 1 2009;100(1):59–64.Google Scholar
  4. 4.
    d’Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Aug 1994;12(8):1673–1684.Google Scholar
  5. 5.
    Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World journal of gastroenterology: WJG. Feb 14 2011;17(6):697–707.Google Scholar
  6. 6.
    Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. May 15 2003;97(10):2462–2473.Google Scholar
  7. 7.
    Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma—results of the prospective German Multicenter Study GIT NHL 01/92. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Sep 15 2001;19(18):3874–3883.Google Scholar
  8. 8.
    Feng L, Zhang G, Hu Z, et al. Diagnosis and treatment of 81 patients with primary gastrointestinal lymphoma. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. Jul 2009;34(7):582–588.Google Scholar
  9. 9.
    Kim SJ, Choi CW, Mun YC, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-Hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC cancer. 2011;11:321.Google Scholar
  10. 10.
    Gou HF, Zang J, Jiang M, Yang Y, Cao D, Chen XC. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma. Med Oncol. Mar 2012;29(1):227–234.Google Scholar
  11. 11.
    Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leukemia & lymphoma. Feb 2004;45(2):339–344.Google Scholar
  12. 12.
    Kim JH, Lee JH, Lee J, et al. Primary NK-/T-cell lymphoma of the gastrointestinal tract: clinical characteristics and endoscopic findings. Endoscopy. Feb 2007;39(2):156–160.Google Scholar
  13. 13.
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. Aug 18 2009;151(4):264–269, W264.Google Scholar
  14. 14.
    Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ journal of surgery. Sep 2003;73(9):712–716.Google Scholar
  15. 15.
    Kim SJ, Kang HJ, Kim JS, et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. Feb 10 2011;117(6):1958–1965.Google Scholar
  16. 16.
    Dawson PJ, Harrison CV. A clinicopathological study of benign Hodgkin’s disease. Journal of clinical pathology. May 1961;14:219–231.Google Scholar
  17. 17.
    Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. Aug 1978;42(2):693–707.Google Scholar
  18. 18.
    Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2009:523–531.Google Scholar
  19. 19.
    Rohatiner A, d’Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397–400.Google Scholar
  20. 20.
    Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol. 1989;7(11):1630–1636.Google Scholar
  21. 21.
    Tang TC, Kuo MC, Chang H, et al. Primary colonic lymphoma: an analysis of 74 cases with localized large-cell lymphoma. Eur J Haematol. Jul 2011;87(1):28–36.Google Scholar
  22. 22.
    Huang WT, Hsu YH, Yang SF, Chuang SS. Primary gastrointestinal follicular lymphoma: a clinicopathologic study of 13 cases from Taiwan. Journal of clinical gastroenterology. Oct 2008;42(9):997–1002.Google Scholar
  23. 23.
    Schmatz AI, Streubel B, Kretschmer-Chott E, et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol. Apr 10 2011;29(11):1445–1451.Google Scholar
  24. 24.
    Zhai L, Zhao Y, Lin L, et al. Non-Hodgkin’s lymphoma involving the ileocecal region: a single-institution analysis of 46 cases in a Chinese population. J Clin Gastroenterol. Jul 2012;46(6):509–514.Google Scholar
  25. 25.
    Lai YL, Lin JK, Liang WY, Huang YC, Chang SC. Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol. Sep 1 2011;104(3):265–268.Google Scholar
  26. 26.
    Gonzalez QH, Heslin MJ, Davila-Cervantes A, et al. Primary colonic lymphoma. Am Surg. Mar 2008;74(3):214–216.Google Scholar
  27. 27.
    Tse E, Gill H, Loong F, et al. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. American journal of hematology. Jul 2012;87(7):663–668.Google Scholar
  28. 28.
    Lee HS, Park LC, Lee EM, et al. Comparison of therapeutic outcomes between surgical resection followed by R-CHOP and R-CHOP alone for localized primary intestinal diffuse large B-cell lymphoma. American journal of clinical oncology. Apr 2014;37(2):182–187.Google Scholar
  29. 29.
    Khosla D, Kumar R, Kapoor R, Kumar N, Bera A, Sharma SC. A retrospective analysis of clinicopathological characteristics, treatment, and outcome of 27 patients of primary intestinal lymphomas. Journal of gastrointestinal cancer. Dec 2013;44(4):417–421.Google Scholar
  30. 30.
    Kobayashi H, Nagai T, Omine K, et al. Clinical outcome of non-surgical treatment for primary small intestinal lymphoma diagnosed with double-balloon endoscopy. Leukemia & lymphoma. Apr 2013;54(4):731–736.Google Scholar
  31. 31.
    Drolet S, Maclean AR, Stewart DA, Dixon E, Paolucci EO, Buie WD. Primary colorectal lymphoma-clinical outcomes in a population-based series. J Gastrointest Surg. Oct 2011;15(10):1851–1857.Google Scholar
  32. 32.
    Wang SL, Liao ZX, Liu XF, et al. Primary early-stage intestinal and colonic non-Hodgkin’s lymphoma: clinical features, management, and outcome of 37 patients. World J Gastroenterol. Oct 7 2005;11(37):5905–5909.Google Scholar
  33. 33.
    She WH, Day W, Lau PY, Mak KL, Yip AW. Primary colorectal lymphoma: case series and literature review. Asian journal of surgery/Asian Surgical Association. Jul 2011;34(3):111–114.Google Scholar
  34. 34.
    Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Jul 15 2003;21(14):2740–2746.Google Scholar
  35. 35.
    Wang GB, Xu GL, Luo GY, et al. Primary intestinal non-Hodgkin’s lymphoma: a clinicopathologic analysis of 81 patients. World J Gastroenterol. Nov 7 2011;17(41):4625–4631.Google Scholar
  36. 36.
    Li B, Shi YK, He XH, et al. Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol. May 2008;87(4):375–381.Google Scholar
  37. 37.
    Hwang HS, Yoon DH, Suh C, Park CS, Huh J. Intestinal diffuse large B-cell lymphoma: an evaluation of different staging systems. Journal of Korean medical science. Jan 2014;29(1):53–60.Google Scholar
  38. 38.
    Musallam KM, Hatoum HA, Barada K, et al. Primary colorectal lymphoma. Med Oncol. Jun 2010;27(2):249–254.Google Scholar
  39. 39.
    Sarkhosh K, Bathe OF, Stewart DA, Mack LA. The role of surgical intervention in the management of duodenal lymphoma. J Surg Oncol. Jun 1 2009;99(7):428–432.Google Scholar
  40. 40.
    Lee J, Kim WS, Kim K, et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res. Mar 2007;31(3):359–364.Google Scholar
  41. 41.
    Bairey O, Ruchlemer R, Shpilberg O. Non-Hodgkin’s lymphomas of the colon. Isr Med Assoc J. Dec 2006;8(12):832–835.Google Scholar
  42. 42.
    Wong MT, Eu KW. Primary colorectal lymphomas. Colorectal Dis. Sep 2006;8(7):586–591.Google Scholar
  43. 43.
    Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. Apr 2003;14(4):623–629.Google Scholar
  44. 44.
    Tari A, Asaoku H, Kunihiro M, Tanaka S, Fujihara M, Yoshino T. Clinical features of gastrointestinal follicular lymphoma: comparison with nodal follicular lymphoma and gastrointestinal MALT lymphoma. Digestion. 2011;83(3):191–197.Google Scholar
  45. 45.
    Na YJ, Kim ER, Kim SJ, Kim WS, Ko YH, Son HJ. Primary gastrointestinal follicular lymphoma: single-center 12-year experiences. Hepato-gastroenterology. May 2012;59(115):751–753.Google Scholar
  46. 46.
    Beaton C, Davies M, Beynon J. The management of primary small bowel and colon lymphoma—a review. International journal of colorectal disease. May 2012;27(5):555–563.Google Scholar
  47. 47.
    Stanojevic GZ, Nestorovic MD, Brankovic BR, Stojanovic MP, Jovanovic MM, Radojkovic MD. Primary colorectal lymphoma: an overview. World journal of gastrointestinal oncology. Jan 15 2011;3(1):14–18.Google Scholar
  48. 48.
    Cirocchi R, Farinella E, Trastulli S, et al. Surgical treatment of primitive gastro-intestinal lymphomas: a systematic review. World journal of surgical oncology. 2011;9:145.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Aviles A, Nambo MJ, Neri N, Talavera A, Cleto S. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Medical oncology. 2005;22(1):57–62.CrossRefPubMedGoogle Scholar
  50. 50.
    Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. British journal of cancer. Apr 1999;79(11–12):1929–1934.Google Scholar
  51. 51.
    Kim KW, Park SY, Lee EH, Ahn CJ, Lee KS. Mucosa-associated lymphoid tissue (MALT) lymphoma combined with tuberculous enteritis at the same site in the jejunum. Leukemia & lymphoma. Sep-Oct 2001;42(5):1151–1155.Google Scholar
  52. 52.
    Ibrahim EM, Ezzat AA, El-Weshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 66 patients. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. Jan 2001;12(1):53–58.Google Scholar
  53. 53.
    Dotan E, Aggarwal C, Smith MR. Impact of rituximab (Rituxan) on the treatment of B-cell non-Hodgkin’s lymphoma. P & T: a peer-reviewed journal for formulary management. Mar 2010;35(3):148–157.Google Scholar
  54. 54.
    Coiffier B. Rituximab in the treatment of diffuse large B-cell lymphomas. Seminars in oncology. Feb 2002;29(1 Suppl 2):30–35.Google Scholar
  55. 55.
    Habermann TM, Weller EA, Morrison VA, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Jul 1 2006;24(19):3121–3127.Google Scholar
  56. 56.
    Li X, Liu Z, Cao J, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group. Annals of hematology. Jun 2012;91(6):837–845.Google Scholar
  57. 57.
    Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Aug 1 2005;23(22):5027–5033.Google Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2015

Authors and Affiliations

  • Amy L. Lightner
    • 1
    Email author
  • Evan Shannon
    • 2
  • Melinda Maggard Gibbons
    • 1
  • Marcia M. Russell
    • 1
    • 3
  1. 1.Department of SurgeryDavid Geffen School of Medicine at the University of California at Los AngelesLos AngelesUSA
  2. 2.Department of MedicineBrigham and Women’s HospitalBostonUSA
  3. 3.VA Greater Los Angeles Healthcare SystemLos AngelesUSA

Personalised recommendations